There was no significant difference between doses, but there was a clear trend towards lower rates of ADE after the booster dose, emphasizing a decrease in the risk of possible disease aggravation due to immunity to a prior SARS-CoV-2 variant. 4.
← all excerpts
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection.
1
—
—